Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter

Summary

The aim of our study was to evaluate the usefulness of color duplex sonography to distinguish Graves' disease from diffuse toxic goiter. 24 patients with Graves' disease and 13 patients with diffuse toxic goiter underwent B-mode- and color duplex sonography of the thyroid gland. All patients had hyperthyroidism and elevated ^99mTc-uptake. Spectral Doppler recordings were obtained at all thyroid arteries. Representative color flow maps of the thyroid gland were analyzed, calculating the percentage area of the thyroid gland, occupied by color pixels (color pixel density). The B-mode ultrasound pattern was subjectively assessed on a 4-point rating scale. In patients with Graves' disease the mean peak systolic velocity (PSV) (SD) was 110 (± 49) cm/s, the mean volume flow rate (VFR) was 123 ( ± 67) ml/min and the mean color pixel density (CPD) was 33 (± 12) %. For patients with diffuse toxic goiter mean PSV (SD) was 43 ( ± 9) cm/s (p < 0.001), mean VFR was 23 (± 10) ml/min (p < 0.001) and mean CPD was 9 (± 6) % (p = 0.007). CPD and spectral duplex recordings were positively correlated (CPD/PSV: r_s = 0.77, CPD/VFR: r_s = 0.75; p < 0.0001). No significant differences were observed concerning RI values. Sensitivity was 87% and specificity 92% for CPD and VFR and 87% and 100% for PSV. We conclude, that color duplex sonography can reliably distinguish diffuse toxic goiter from Graves' disease and therefore contributes significantly to the differential diagnosis of hyperthyroidism in diffuse thyroid disease.

Key words:

Graves' disease - Disseminated autonomy - Antibody-negative hyperthyroidism - Color Doppler sonography - Hyperthyroidism - Vascularity

References

• 1 Armstrong D I, Rogers T G, Brownlie B E, Turner J G. Thyroid vascularity and trapping function: analysis of very early thyroidal technecium “uptake”.  Int J Nucl Med Biol. 1976;  3 65-70
• 2 Bogazzi F, Bartalena L, Brogioni S, Burelli A, Manetti L, Tanda M L, Gasperi M, Martino E. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow Doppler sonography.  Eur J Endocrinol. 1999;  140 452-456
• 3 Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E. Color flow Doppler sonography rapidly differentiates type I and type II amiodaron-induced thyrotoxicosis.  Thyroid. 1997;  7 541-545
• 4 Bogazzi F, Bartalena L, Vitti P, Rago T, Brogioni S, Martino E. Color flow Doppler sonography in thyrotoxicosis factitia.  J Endocrinol Invest. 1996;  19 603-606
• 5 Castagnone D, Rivolta R, Rescalli S, Baldini M I, Tozzi R, Cantalamessa L. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome.  Am J Roentgenol. 1996;  166 203-207
• 6 Fobbe F. Thyroid gland. In: Wolf KJ, Fobbe F (eds) Color Duplex Sonography Thieme Medical Publishers, New York 1995: 217-224
• 7 Metz C. Basic principles of ROC analysis.  Semin Nucl Med. 1978;  8 283-298
• 8 Ralls P W, Mayekawa D S, Lee K P, Colletti P M, Radin R D, Boswell W D, Halls J M. Color-flow Doppler sonography in Graves Disease: “thyroid inferno”.  Am J Roentgenol. 1988;  150 781-784
• 9 Tegler L, Gillquist J, Anderberg B, Lundstrom B, Johansson H. Thyroid blood flow rate in man. Electromagnetic flowmetry during operation in euthyroid normal gland, nontoxic goiter, and hyperthyroidism.  J Endocrinol Invest. 1981;  4 335-341
• 10 Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, DeLiperi A, Bartolozzi C, Pinchera A, Martino E. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.  J Endocrinol Invest. 1995;  18 857-861
• 11 Zachrisson B F. Thyroid angiography.  Acta Radiol (Copenh). ((Suppl 1)) 1976;  1-112
• 12 Zingrillo M, D'Aloiso L, Ghiggi M R, Di Cerbo A, Chiodini I, Torlontano M, Liuzzi A. Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?.  Clin Endocrinol. 1996;  45 201-206